Biogen (BIIB) Financials
Biogen (BIIB) Historical Financial Statements and Key Metrics for 1985 - 2025
Full Biogen financials for 1985 - 2025 are available in the
US Historical Financials dataset
All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.
Biogen Income Statements
(in $ 000,000's)
| Quarter End | Revenue | Gross Profit | Operating Income | Net Income | EBITDA | EPS |
| 2025-Mar-31 | 2,431 | 1,802 (74.1 %) | 625 (25.7 %) | 240 (9.9 %) | 554 | 1.65 |
| 2024-Dec-31 | 2,455 | 2,455 (100.0 %) | 1,242 (50.6 %) | 267 (10.9 %) | 0 | 1.83 |
| 2024-Sep-30 | 2,466 | 1,827 (74.1 %) | 496 (20.1 %) | 388 (15.8 %) | 694 | 2.66 |
| 2024-Jun-30 | 2,353 | 1,648 (70.0 %) | 652 (27.7 %) | 584 (24.8 %) | 811 | 4.00 |
| 2024-Mar-31 | 2,200 | 1,510 (68.6 %) | 545 (24.8 %) | 393 (17.9 %) | 693 | 2.70 |
| 2023-Dec-31 | 2,386 | 1,768 (74.1 %) | 292 (12.2 %) | 250 (10.5 %) | 623 | 1.71 |
| 2023-Sep-30 | 2,530 | 1,871 (73.9 %) | -141 (-5.6 %) | -68 (-2.7 %) | 372 | -0.47 |
Full historical income statements for 1985 - 2025 is included in the
US Historical Financials dataset.
Biogen Balance Sheets
(in $ 000,000's)
| Quarter End | Total Assets | Total Liabilities | Total Debt | Total Equity | Cash & Equivalents |
| 2025-Mar-31 | 28,033 | 11,054 | 6,621 | 16,979 | 2,598 |
| 2024-Dec-31 | 28,049 | 11,333 | 4,882 | 17,448 | 2,375 |
| 2024-Sep-30 | 28,313 | 11,954 | 6,651 | 16,359 | 1,699 |
| 2024-Jun-30 | 26,804 | 10,915 | 6,852 | 15,889 | 1,909 |
| 2024-Mar-31 | 26,568 | 11,355 | 6,947 | 15,213 | 1,074 |
| 2023-Dec-31 | 26,845 | 12,045 | 7,338 | 14,799 | 1,050 |
| 2023-Sep-30 | 28,193 | 13,714 | 7,715 | 14,480 | 2,288 |
Full historical balance sheet data for 1985 - 2025 is included in the
US Historical Financials dataset.
Biogen Cash Flow Statements
(in $ 000,000's)
| Quarter End | Operating Cash Flow | Investing | Financing | Free Cash Flow |
| 2025-Mar-31 | 259 | -47 | -23 | 212 |
| 2024-Dec-31 | 761 | -19 | 8 | 800 |
| 2024-Sep-30 | 936 | -1,181 | -7 | 806 |
| 2024-Jun-30 | 626 | 466 | -245 | 583 |
| 2024-Mar-31 | 553 | -66 | -440 | 432 |
| 2023-Dec-31 | 12 | -652 | -646 | -53 |
| 2023-Sep-30 | 592 | -1,742 | 849 | 505 |
Full historical cash flow data for 1985 - 2025 is included in the
US Historical Financials dataset.
Biogen Key Valuation and Operating Metrics
| Quarter End | Market Capitalization ($ 000,000's) |
Enterprise Value ($ 000,000's) |
Price/Earnings ($ 000,000's) |
Price/Sales ($ 000,000's) |
Price/Book ($ 000,000's) |
| 2025-Mar-31 | 19,992 | 24,015 | 8.22 | 20.78 | 1.18 |
| 2024-Dec-31 | 22,280 | 24,787 | 9.08 | 20.88 | 1.28 |
| 2024-Sep-30 | 28,242 | 33,194 | 11.45 | 18.17 | 1.73 |
| 2024-Jun-30 | 33,746 | 38,689 | 14.34 | 14.46 | 2.12 |
| 2024-Mar-31 | 31,193 | 37,066 | 14.18 | 19.82 | 2.05 |
| 2023-Dec-31 | 37,496 | 43,784 | 15.71 | 37.54 | 2.53 |
| 2023-Sep-30 | 37,215 | 42,642 | 14.71 | -136.62 | 2.57 |
Full historical valuation and operating metrics for 1985 - 2025 are included in the
US Historical Financials dataset.